METHOD OF PRODUCING A LINE OF LYM-2 HYBRIDE CELLS AND METHOD OF PRODUCING LYM-2 ANTIGENS

摘要

Hybridoma Lym-2 (ATCC No. HB 8613) produces murine IgGl monoclonal antibodies specifically against normal human B cells and derived malignancies. The Lym-2 antibodies have possible clinical utility for the in vivo diagnosis and therapy of human B-cell lumphomas and leukemias.